HORSHOLM, Denmark, Oct. 5, 2012 /PRNewswire/ — Veloxis Pharmaceuticals A/S (OMX: VELO) today announced that it has entered into an exclusive distribution agreement with Chiesi Farmaceutici S.p.A, a fully …
Pfizer to appeal over India drug patent refusalNew York Daily NewsAccording to Pfizer representatives, the court's decision undermines intellectual property rights in India. Indian pharmaceutical company Cipla opposed the granting of the domestic p…
Belgium pioneers organ donation from euthanased patientsBioEdgeThe practice of transplanting organs from patients who die after voluntary euthanasia is becoming relatively common in Belgium. A leading specialist, Dirk Van Raemdonck, told a conference i…
India revokes patent on Sutent, Pfizer to appealPharma TimesSutent (sunitinib) a treatment for liver and kidney cancer, was granted a patent in India in 2007 but that decision was challenged by generics specialist Cipla and Natco Pharma. India's Pa…
Published: Thursday, October 4, 2012 at 12:42 PM. Congratulations to four more Craven County citizens (from Havelock to Vanceboro) who recently received kidney transplants from ECU Kidney Transplant Surgery and Vidant Medical Center. Led by ECU physici…
Pfizer to appeal over India drug patent refusalAFPIndian generics drugs heavyweight Cipla teamed up with other generic local pharmaceutical companies to oppose the granting of the domestic patent for Sutent, which is used to fight liver and kidney canc…
Janssen adds Astellas JAK inhibitor to its immunology portfolioPMLiVEAstellas will continue its in-house development of the drug for the prevention of organ transplant rejection, where the clinical programme has reached phase II. Meanwhile, Pfizer'…
Lonza Drops on Roche Drug Copy Testing Concerns: Zurich MoverBusinessweekTeva and Lonza have not started phase III trials for rituximab, a generic copy of Rituxan, Dirk Oehlers, a spokesman for Lonza, said by telephone. The company is evaluating how to…
Lonza Drops on Roche Drug Copy Testing Concerns: Zurich MoverBloombergTeva and Lonza have not started phase III trials for rituximab, a generic copy of Rituxan, Dirk Oehlers, a spokesman for Lonza, said by telephone. The company is evaluating how to mo…
DDL blood donationStabroek NewsDDL blood donation: Staff members of Demerara Distillers Limited recently donated 30 units of blood to the National Blood Bank. Blood donor recruiter Shazim Sookram expressed appreciation to the company. In photo a DDL st…